MariTide (Amgen) is a once-monthly injectable that acts as a GIP antagonist combined with a GLP-1 agonist, showing roughly 12% to 16% weight loss in Phase 2 and now in Phase 3
It supports the bodys natural processes in building muscle, reducing fat, and improving overall cellular function
Retrieved May 3, 2025, from (Notes that riboflavin is a key coenzyme in energy metabolism
GHK-Copper has a comparatively substantial research literature for a peptide, particularly in skin biology, covering collagen synthesis, elastin, and extracellular matrix remodeling
Presented for research literature review only Bleuel C et al
That's a powerful idea in early research and powerful is precisely why it isn't something to experiment with on your own